Drugs / YiQiFuMai
YiQiFuMai
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05265130 | Feb 2022 → Jan 2024 | infectious disease with sepsis | Xiyuan Hospital of China Academy of Chinese Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YiQiFuMai | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05265130 ↗ |
| Known as | YiQiFuMai Injection | “YiQiFuMai Injection (YQFM) is a redeveloped preparation based on the traditional Chinese medicine formula Sheng-Mai-San” NCT05265130 ↗ |
| Known as | YQFM | “YiQiFuMai Injection (YQFM) is a redeveloped preparation based on the traditional Chinese medicine formula Sheng-Mai-San” NCT05265130 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “YQFM is a redeveloped preparation based on the traditional Chinese medicine formula Sheng-Mai-San” NCT05265130 ↗ |
| Route | Intravenous | “YQFM 5.2g in 0.9% Normal Saline 250ml IV” NCT05265130 ↗ |